• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验室和临床结核分枝杆菌菌株的转录组分析表明,接触德拉马尼后会发生呼吸中毒。

Transcriptional profiling of a laboratory and clinical Mycobacterium tuberculosis strain suggests respiratory poisoning upon exposure to delamanid.

机构信息

Scientific Service Bacterial Diseases - Infectious Diseases in Humans, Sciensano, Juliette Wytsmanstraat 14, 1050 Brussels, Belgium; National Reference Center of Mycobacteria and Tuberculosis - Infectious Diseases in Humans, Sciensano, Juliette Wytsmanstraat 14, 1050 Brussels, Belgium.

Institut Pasteur - Transcriptome and Epigenome Platform - Biomics Pole - C2RT, 28 Rue du Docteur Roux, 75015 Paris, France; Institut Pasteur - Bioinformatics and Biostatistics Hub - C3BI, USR 3756 IP CNRS, 28 Rue du Docteur Roux, 75015 Paris, France.

出版信息

Tuberculosis (Edinb). 2019 Jul;117:18-23. doi: 10.1016/j.tube.2019.05.002. Epub 2019 May 15.

DOI:10.1016/j.tube.2019.05.002
PMID:31378263
Abstract

Tuberculosis (TB) is the most deadly infectious disease worldwide. To reduce TB incidence and counter the spread of multidrug resistant TB, the discovery and characterization of new drugs is essential. In this study, the transcriptional response of two Mycobacterium tuberculosis strains to a pressure of the recently approved delamanid is investigated. Total RNA sequencing revealed that the response to this bicyclic nitroimidazole shows many similarities with pretomanid, an anti-tuberculous drug from the same class. Although delamanid is found to inhibit cell wall synthesis, the expression of genes involved in this process were only mildly affected. In contrast, a clear parallel was found with components that affect aerobic respiration. This demonstrates that, besides the inhibition of cell wall synthesis, respiratory poisoning plays a fundamental role in the bactericidal effect of delamanid. Remarkably, the most highly induced genes comprise poorly characterized genes for which functional characterization might hint to the target molecule(s) of delamanid and its exact mode(s) of action.

摘要

结核病(TB)是全球最致命的传染病。为了降低结核病的发病率并遏制耐多药结核病的传播,发现和鉴定新的药物至关重要。在这项研究中,研究人员调查了两种结核分枝杆菌菌株对最近批准的德拉马尼的压力的转录反应。全转录组测序显示,这种双环硝基咪唑对这种双环硝基咪唑的反应与同类抗结核药物普托马尼有许多相似之处。尽管德拉马尼被发现抑制细胞壁合成,但参与这一过程的基因的表达仅受到轻微影响。相比之下,与影响有氧呼吸的成分明显平行。这表明,除了抑制细胞壁合成外,呼吸中毒在德拉马尼的杀菌作用中起着根本性的作用。值得注意的是,诱导表达最强的基因包括功能特征描述较差的基因,对这些基因的功能特征描述可能提示德拉马尼及其确切作用模式的靶分子(s)。

相似文献

1
Transcriptional profiling of a laboratory and clinical Mycobacterium tuberculosis strain suggests respiratory poisoning upon exposure to delamanid.实验室和临床结核分枝杆菌菌株的转录组分析表明,接触德拉马尼后会发生呼吸中毒。
Tuberculosis (Edinb). 2019 Jul;117:18-23. doi: 10.1016/j.tube.2019.05.002. Epub 2019 May 15.
2
Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis.比较硝基咪唑类药物德拉马尼和普托马尼对耐多药和广泛耐药结核病的体外活性。
Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1293-1296. doi: 10.1007/s10096-019-03551-w. Epub 2019 Apr 5.
3
Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).地拉米定:从发现到用于治疗肺部耐多药结核病(MDR-TB)。
Tuberculosis (Edinb). 2018 Jul;111:20-30. doi: 10.1016/j.tube.2018.04.008. Epub 2018 May 3.
4
Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea.韩国耐多药和广泛耐药结核病中德拉马尼、贝达喹啉和利奈唑胺最低抑菌浓度分布及耐药相关基因突变。
Ann Lab Med. 2018 Nov;38(6):563-568. doi: 10.3343/alm.2018.38.6.563.
5
Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis.抗结核药物地拉马尼的耐药机制
Tuberculosis (Edinb). 2018 Jan;108:186-194. doi: 10.1016/j.tube.2017.12.006. Epub 2017 Dec 30.
6
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical Concentration.地拉曼德(OPC-67683)对结核分枝杆菌临床分离株的最低抑菌浓度及建议的临界浓度。
Antimicrob Agents Chemother. 2016 May 23;60(6):3316-22. doi: 10.1128/AAC.03014-15. Print 2016 Jun.
7
Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.使用配备TB eXiST的MGIT 960系统测定结核分枝杆菌中贝达喹啉和地拉曼的最低抑菌浓度分布及流行病学截断值。
Antimicrob Agents Chemother. 2015 Jul;59(7):4352-5. doi: 10.1128/AAC.00614-15. Epub 2015 May 4.
8
Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.使用刃天青微量滴定法和BACTEC™ MGIT™ 960系统对结核分枝杆菌进行地拉曼id药敏试验。
J Antimicrob Chemother. 2016 Jun;71(6):1532-9. doi: 10.1093/jac/dkw044. Epub 2016 Apr 13.
9
Delamanid or pretomanid? A Solomonic judgement!德拉马尼还是普雷马尼?这真是一个棘手的问题!
J Antimicrob Chemother. 2022 Mar 31;77(4):880-902. doi: 10.1093/jac/dkab505.
10
Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering.利用蛋白质工程预测结核分枝杆菌中的硝基咪唑类抗生素耐药突变。
PLoS Pathog. 2020 Feb 7;16(2):e1008287. doi: 10.1371/journal.ppat.1008287. eCollection 2020 Feb.

引用本文的文献

1
Defining the mechanism of action of the nitrofuranyl piperazine HC2210 against Mycobacterium abscessus.确定硝基呋喃基哌嗪HC2210对脓肿分枝杆菌的作用机制。
NPJ Antimicrob Resist. 2025 Jun 14;3(1):55. doi: 10.1038/s44259-025-00124-0.
2
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers.利用RNA生物标志物加速结核分枝杆菌药敏试验
EBioMedicine. 2025 Mar;113:105611. doi: 10.1016/j.ebiom.2025.105611. Epub 2025 Feb 25.
3
Functions of nitroreductases in mycobacterial physiology and drug susceptibility.
硝基还原酶在分枝杆菌生理学和药物敏感性中的作用。
J Bacteriol. 2025 Feb 20;207(2):e0032624. doi: 10.1128/jb.00326-24. Epub 2025 Jan 8.
4
Innovative Bedaquiline-Based Delivery Systems for Multidrug-Resistant Tuberculosis Treatment.用于耐多药结核病治疗的基于贝达喹啉的创新给药系统。
Infect Disord Drug Targets. 2025;25(4):e18715265318306. doi: 10.2174/0118715265318306240816104553.
5
CRISPR Screening and Comparative LC-MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis.CRISPR 筛选和比较 LC-MS 分析鉴定了影响达玛烷和普托马尼德对结核分枝杆菌疗效的基因。
Adv Sci (Weinh). 2024 Oct;11(39):e2400176. doi: 10.1002/advs.202400176. Epub 2024 Aug 20.
6
Transcriptomic responses to antibiotic exposure in .抗生素暴露对. 的转录组反应。
Antimicrob Agents Chemother. 2024 May 2;68(5):e0118523. doi: 10.1128/aac.01185-23. Epub 2024 Apr 8.
7
Discovery and characterization of antimycobacterial nitro-containing compounds with distinct mechanisms of action and efficacy.发现并鉴定具有不同作用机制和疗效的抗分枝杆菌含硝基化合物。
Antimicrob Agents Chemother. 2023 Sep 19;67(9):e0047423. doi: 10.1128/aac.00474-23. Epub 2023 Aug 23.
8
DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid.DprE2 是抗结核硝基咪唑化合物丙硫异烟胺和德拉马尼的分子靶标。
Nat Commun. 2023 Jun 28;14(1):3828. doi: 10.1038/s41467-023-39300-z.
9
Nitrobenzoates and Nitrothiobenzoates with Activity against .具有抗……活性的硝基苯甲酸酯和硝基硫代苯甲酸酯
Microorganisms. 2023 Apr 8;11(4):969. doi: 10.3390/microorganisms11040969.
10
NOS2/miR-493-5p Signaling Regulates in the LPS-Induced Inflammatory Response in the RAW264.7 Cells.NOS2/miR-493-5p信号通路调控RAW264.7细胞中脂多糖诱导的炎症反应。
Biochem Genet. 2023 Jun;61(3):1097-1112. doi: 10.1007/s10528-022-10297-2. Epub 2022 Nov 30.